Where is the live CopyMark page for USPTO serial 79263962?

The live record is at https://getcopymark.com/trademark/79263962. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns INNOPEUTICS?

According to the public USPTO record for serial number 79263962, the listed owner(s) include: INNOPEUTICS corporation, INNOPEUTICS corporation, INNOPEUTICS corporation.

What is USPTO serial number 79263962?

Serial number 79263962 is the USPTO application identifier for the mark INNOPEUTICS. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover INNOPEUTICS?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: INNOPEUTICS Serial# 79263962 | status 711; last event NCS7 | Trademark Info & Attorney Guidance

Q: What is the current status of INNOPEUTICS?

INNOPEUTICS (79263962) currently shows USPTO status code 711 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INNOPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

Yoon S. Ham HAUPTMAN HAM, LLP2318 MILL ROADSUITE 1400ALEXANDRIA, VA 22314

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of leukemia; Pharmaceutical preparations for the treatment of cells; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases; Biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; Pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; Pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; Pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of central nervous system diseases	SECTION 7(e) - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jul 2, 2026	NCS7	NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED	—
Jul 2, 2026	C7..	CANCELLED SECTION 7-TOTAL	—
Jul 2, 2026	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Jun 26, 2026	C7RF	REQUEST FOR SECT 7 TOTAL SURRENDER FILED	—
Jun 26, 2026	ES7S	TEAS SECTION 7 SURRENDER RECEIVED	—
Feb 25, 2025	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Apr 30, 2021	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Jul 17, 2020	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Jun 26, 2020	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Jun 26, 2020	FIMP	FINAL DISPOSITION PROCESSED	—
May 25, 2020	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Feb 25, 2020	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 10, 2019	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Dec 10, 2019	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2019	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Nov 3, 2019	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 18, 2019	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Oct 18, 2019	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	—
Oct 18, 2019	GNEA	EXAMINERS AMENDMENT E-MAILED	—
Oct 18, 2019	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Oct 5, 2019	RFNT	REFUSAL PROCESSED BY IB	—
Oct 5, 2019	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Oct 5, 2019	CHAN	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	—
Oct 4, 2019	ALIE	ASSIGNED TO LIE	—
Sep 27, 2019	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Sep 27, 2019	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2019	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2019	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Sep 13, 2019	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Sep 13, 2019	RFRR	REFUSAL PROCESSED BY MPU	—
Aug 28, 2019	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Aug 27, 2019	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2019	DOCK	ASSIGNED TO EXAMINER	—
Aug 3, 2019	MAFR	APPLICATION FILING RECEIPT MAILED	—
Jul 30, 2019	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jul 25, 2019	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

INNOPEUTICS